Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...

This story is part of a Seattle Times focus on the affordability crisis in the Northwest. We explore the high cost of living and wealth disparities that shape our region; examine policies that impact ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

The US military used a range of weapons, including missiles and drones, to strike Iran on Saturday. American forces also relied on top air defenses to shoot down Iranian retaliatory strikes. Iran has ...

A decision tree regression system incorporates a set of if-then rules to predict a single numeric value. Decision tree regression is rarely used by itself because it overfits the training data, and so ...

Using Science to Improve the BLM Wild Horse and Burro Program: A Way Forward reviews the science that underpins the Bureau of Land Management's oversight of free-ranging horses and burros on federal ...

Amid a push toward AI agents, with both Anthropic and OpenAI shipping multi-agent tools this week, Anthropic is more than ready to show off some of its more daring AI coding experiments. But as usual ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Steve Bannon, a former White House adviser to President Donald Trump, ...

Recently, I used Costco's Auto Program to save thousands of dollars when buying a car. It was easy to use, and I liked that I didn't have to negotiate or haggle with a dealership. More Costco members ...

Sarah Bradley is a writer with six years of experience creating personal essays, reported features, and content related to health and parenting topics. Susan Bard, MD, is a board-certified general and ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...